Literature DB >> 19656152

Influence of PI-3K/Akt pathway on Wnt signalling in regulating myeloid progenitor cell proliferation. Evidence for a role of autocrine/paracrine Wnt regulation.

Georgios Nteliopoulos1, Stephen B Marley, Myrtle Y Gordon.   

Abstract

The regulation of myeloid progenitor cell (granulocyte-macrophage colony-forming units, CFU-GM) proliferation/differentiation by the Wnt and phosphatidylinositol-3 kinase (PI-3K) pathways was investigated using a colony-replating assay. The PI-3K pathway promoted differentiation of interleukin-3 (IL-3)-stimulated myelopoiesis via Akt, because inhibition of the PI-3K/Akt pathway with LY294002 or SH-5 increased proliferation. The involvement of canonical and non-canonical Wnt pathways was investigated using Wnt3a and Wnt5a respectively. Addition of the recombinant Wnts to IL-3 increased CFU-GM proliferation. Dkk-1, when combined with the Wnt proteins, abrogated the effects of Wnt3a but not Wnt5a. Surprisingly, the addition of Dkk-1 to LY294002 or SH-5 blocked their proliferative effects. We hypothesized that increased proliferation induced by PI-3K/Akt inhibitors was not mediated by downstream activation of the Wnt pathway but by induced endogenous production/release of Wnt proteins. The addition of SH-5 to IL-3 created an autocrine Wnt loop in CD34(+) cells, resulting in the phosphorylation of lipoprotein-receptor-related-protein 6. Furthermore, the addition of medium conditioned by CD34(+) cells cultured in IL-3 + SH-5 to IL-3 increased CFU-GM proliferation. This effect was abrogated by Dkk-1, suggesting that a Wnt in the conditioned medium increased proliferation. In summary, IL-3 via the PI-3K pathway promoted differentiation of myeloid progenitor cells through a decrease of endogenous Wnt production/release.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19656152     DOI: 10.1111/j.1365-2141.2009.07823.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  7 in total

1.  ARK5 is associated with the invasive and metastatic potential of human breast cancer cells.

Authors:  Xin-Zhong Chang; Jie Yu; Hai-Yin Liu; Rui-Hua Dong; Xu-Chen Cao
Journal:  J Cancer Res Clin Oncol       Date:  2011-11-22       Impact factor: 4.553

Review 2.  Regulation of angiogenesis via Notch signaling in breast cancer and cancer stem cells.

Authors:  Weiqiang Zhou; Guangdi Wang; Shanchun Guo
Journal:  Biochim Biophys Acta       Date:  2013-10-30

3.  INPP4B promotes PI3Kα-dependent late endosome formation and Wnt/β-catenin signaling in breast cancer.

Authors:  Samuel J Rodgers; Lisa M Ooms; Viola M J Oorschot; Ralf B Schittenhelm; Elizabeth V Nguyen; Sabryn A Hamila; Natalie Rynkiewicz; Rajendra Gurung; Matthew J Eramo; Absorn Sriratana; Clare G Fedele; Franco Caramia; Sherene Loi; Genevieve Kerr; Helen E Abud; Georg Ramm; Antonella Papa; Andrew M Ellisdon; Roger J Daly; Catriona A McLean; Christina A Mitchell
Journal:  Nat Commun       Date:  2021-05-25       Impact factor: 14.919

4.  Gene expression profiling reveals new aspects of PIK3CA mutation in ERalpha-positive breast cancer: major implication of the Wnt signaling pathway.

Authors:  Magdalena Cizkova; Géraldine Cizeron-Clairac; Sophie Vacher; Aurélie Susini; Catherine Andrieu; Rosette Lidereau; Ivan Bièche
Journal:  PLoS One       Date:  2010-12-30       Impact factor: 3.240

5.  Divergent effects of Wnt5b on IL-3- and GM-CSF-induced myeloid differentiation.

Authors:  Marina Mastelaro de Rezende; John-Poul Ng-Blichfeldt; Giselle Zenker Justo; Edgar Julian Paredes-Gamero; Reinoud Gosens
Journal:  Cell Signal       Date:  2019-12-17       Impact factor: 4.315

Review 6.  The Role of Notch and Wnt Signaling in MSC Communication in Normal and Leukemic Bone Marrow Niche.

Authors:  Paul Takam Kamga; Riccardo Bazzoni; Giada Dal Collo; Adriana Cassaro; Ilaria Tanasi; Anna Russignan; Cristina Tecchio; Mauro Krampera
Journal:  Front Cell Dev Biol       Date:  2021-01-08

Review 7.  Wnt-5A/B Signaling in Hematopoiesis throughout Life.

Authors:  Marina Mastelaro de Rezende; Giselle Zenker Justo; Edgar Julian Paredes-Gamero; Reinoud Gosens
Journal:  Cells       Date:  2020-07-29       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.